Seventh retraction appears for cancer researcher who sued PubPeer commenters

sarkar
Fazlul Sarkar

Fazlul Sarkar, who sued PubPeer commenters for criticizing his work, has logged two more retractions, bringing his total to seven.

The two retractions appear in the Journal of Cellular Physiology, and follow five others released last week by another Wiley journal, Journal of Cellular Biochemistry. All notices mention an investigation at Wayne State University, where Sarkar is on the faculty.

Here’s the notice for “Activated K-Ras and INK4a/Arf Deficiency Promote Aggressiveness of Pancreatic Cancer by Induction of EMT Consistent With Cancer Stem Cell Phenotype:” Continue reading Seventh retraction appears for cancer researcher who sued PubPeer commenters

JAMA authors retract (and replace) paper about moves and kids’ mental health

JAMAJAMA authors have retracted — and replaced — a 2014 paper about the mental health effects of household moves on kids, after they found errors while completing an additional analysis.

The original paper concluded that in “families who moved out of high-poverty neighborhoods, boys experienced an increase and girls a decrease in rates of depression and conduct disorder,” according to a press release issued by the journal along with the paper (which also got some press attention from Reuters). But part of that conclusion is wrong.

The authors write in a notice for “Associations of Housing Mobility Interventions for Children in High-Poverty Neighborhoods With Subsequent Mental Disorders During Adolescence” that:

Continue reading JAMA authors retract (and replace) paper about moves and kids’ mental health

Researcher suing PubPeer commenters earns 5 retractions following investigation

sarkar
Fazlul Sarkar

An investigation at Wayne State University has prompted five retractions for a scientist who is suing PubPeer commenters after they criticized his work on the site.

The investigation into Fazlul Sarkar and his co-authors found that the papers contain images that were “inappropriately manipulated” or “inappropriately re-used and re-labeled.” All five retraction notices are from the Journal of Cellular Biochemistry.

Here’s the retraction notice for “Concurrent inhibition of NF-κB, cyclooxygenase-2, and epidermal growth factor receptor leads to greater anti-tumor activity in pancreatic cancer:

Continue reading Researcher suing PubPeer commenters earns 5 retractions following investigation

More than $100M worth of research may be tainted by govt lab misconduct

usgsMisconduct by a chemist at a Colorado lab run by the U.S. Geological Survey (USGS) has potentially affected  24 research and assessment projects, supported by $108 million in federal funding, government officials have disclosed.

According to a June 15 statement from the Office of the Inspector General of the U.S. Department of the Interior, which oversees the USGS, the operator of a mass spectrometer in the Inorganic Section of the Energy Resources Program’s (ERP) Energy Geochemistry Laboratory in Lakewood has been accused of scientific misconduct and manipulating data. The unit is responsible for conducting coal and water quality assessments in projects both in the United States and abroad.

The inorganic section closed following the discovery of the misconduct, and we have yet to learn the fate of the employee involved. As the statement notes, problems with the lab’s data were common knowledge among workers at the facility: Continue reading More than $100M worth of research may be tainted by govt lab misconduct

JAMA: No plan to retract article on fetal pain, despite outcry from anti-abortion activists

JAMAJAMA has announced it does not intend to retract a 2005 review article about fetal pain, despite requests from anti-abortion activists who claim it has been misused in debates about the procedure.

Earlier this month, JAMA told one anti-abortion critic that it would take a look at the paper, which suggested that fetuses can’t feel pain before the third trimester. Critics have argued that newer findings have shown pain sensation appears earlier in gestation, yet the 2005 data continue to be cited in the discussion around abortion. What’s more, critics have lamented that some of the authors failed to mention their ties to the abortion industry.

But in a letter sent yesterday to James Agresti, Howard Bauchner, Editor in Chief at JAMA and The JAMA Network, writes: Continue reading JAMA: No plan to retract article on fetal pain, despite outcry from anti-abortion activists

How does Jeremy Berg plan to address reproducibility in Science?

Jeremy Berg
Jeremy Berg, via AAAS

The former director of the National Institute of General Medical Sciences at the U.S. National Institutes of Health has a new job. On July 1st, biochemist Jeremy Berg will take the helm as the editor-in-chief of Science. He’s currently the associate senior vice chancellor for science strategy and planning in the health sciences at the University of Pittsburgh. We spoke to him about challenges he’ll be facing in his new role: treating science’s replication problem, boosting transparency, and making papers as widely available as possible.  

You told us in an earlier conversation that diagnosing and treating science’s replication problem is major issue in publishing. Can you give us some specifics about how you plan to address it at Science? Continue reading How does Jeremy Berg plan to address reproducibility in Science?

Authors retract surgery study that claimed to be randomized but wasn’t

spine-coverThe authors of a study about spinal fusion surgery have retracted it after realizing the cohort study was described as a prospective, randomized trial

The last author told us he believed the incorrect wording was added to the paper — and the title — by accident. Even though he said the journal Spine suggested correcting it, the authors chose to retract the paper entirely.

The abstract of the study describes the design as a:

Prospective, randomized, controlled trial.

But according to the retraction notice for “Prospective, randomized, controlled trial of silicate-substituted calcium phosphate versus rhBMP-2 in a minimally invasive transforaminal lumbar interbody fusion,” the abstract was not accurate:

Continue reading Authors retract surgery study that claimed to be randomized but wasn’t

Fraudster loses third attempt to remove 7-year debarment

court caseA U.S. judge has denied a virology researcher’s third attempt to overturn a seven-year debarment from receiving federal funds, following a 2010 decision by the U.S. Office of Research Integrity.

The ORI banned Scott Brodie for seven years after concluding he had committed 15 acts of misconduct at the University of Washington. The deception affected grant applications, published papers, manuscripts, and presentations. Since then, Brodie has tried multiple times to reverse the ruling in court.

In the latest decision, dated June 13, United States District Judge James E. Boasberg writes: Continue reading Fraudster loses third attempt to remove 7-year debarment

Environmental group alleges scientific fraud in disputed methane studies

icn-logoNote: We are reprinting below an article originally published at InsideClimate News.

The inspector general of the U.S. Environmental Protection Agency has been asked to examine whether a significant recent study of greenhouse gas emissions from oil and gas fields was technically flawed—and whether researchers brushed aside concerns that methane pollution was being understated.

The emission of methane, a much more potent greenhouse gas in the short term than carbon dioxide, has proven difficult to measure. The latest complaint is a volley in a long-running skirmish among academics, advocacy groups and regulators over how tightly methane should be regulated.

On Wednesday, a North Carolina environmental advocacy group, NC Warn, alleged that this dispute has risen to the level of fraud. Continue reading Environmental group alleges scientific fraud in disputed methane studies

Columbia investigation reveals researcher faked data — and a degree

InnateImmunityA researcher faked data and a masters degree, according to an investigation by Columbia University.

He’s also earned his fourth retraction. The new notice, along with one we’ve uncovered from 2014, provide some information on the extent of the deception of Robert Frumento, who left Columbia a decade ago, around the time that the now-retracted papers were published.

Here’s the new retraction notice:

Continue reading Columbia investigation reveals researcher faked data — and a degree